We came across a bullish thesis on Sarepta Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc.'s share was trading at $21.55 as of December 15th. SRPT’s trailing and forward P/E were 169.47 and 17.39 respectively according to Yahoo Finance.
[caption id="attachment_615398" align="aligncenter" width="750"]Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.